RT Journal Article
SR Electronic
T1 Comparison of tumor to normal tissue count ratio using static and SPECT images
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 2243
OP 2243
VO 50
IS supplement 2
A1 Manalang, Kathy
A1 Gates, Vanessa
A1 Salem, Raid
A1 McDonald, Nancy
A1 Spies, Stewart
YR 2009
UL http://jnm.snmjournals.org/content/50/supplement_2/2243.abstract
AB 2243 Objectives Radioembolization using Yittrium-90 (Y-90) microspheres treatment for unresectable hepatic tumor requires image analysis using Tc-99m macro aggregated albumin (MAA) administered through a hepatic artery. The purpose of this research is to determine if static image analysis compared to SPECT analysis significantly affects the calculated tumor to normal ratios (TN). Methods Forty- seven patients with metastatic hepatic tumor were administered approximately 148 MBq of MAA. Following administration, static and SPECT images were obtained. TN were calculated using two different methods. First method used count data from regions of interest (ROI) drawn on SPECT images and was calculated as the counts per voxel for an iso-contour ROI based on the FWHM from the tumor divided by the counts per voxel for adjacent normal tissue. Second method used count data from an iso-contour ROI drawn on static images and was calculated as the average counts from tumor tissue divided by the average counts from adjacent normal tissue. The two methods were compared using Student’s T-test. Results Average TN from the method using the SPECT data was 5.1 ± 4.9 (range of 0.8 and 22.3). The average TN from static image analysis was 2.5 ± 0.8 (range of 1.2 and 4.3). The difference is a statistically significant (p-value = 0.0005). Conclusions TN range from SPECT analysis is wider when compared to the TN from static image analysis suggesting that the SPECT method may be more representative of the hetero-distribution of the microspheres within tumorous tissue. With the use of SPECT imaging, a more representative distribution of microspheres can lead to a better understanding of the effective treatment dose using Y-90 microspheres treatment for metastatic hepatic tumors.